Chromis Lands $3,000,000 Seed Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d2c842b0-707c-4674-b6a1-d4fbbf30f618 - Date
2/29/2016 - Company Name
Chromis - Mailing Address
6605 Nancy Ridge Dr. San Diego, CA 92121 USA - Company Description
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. - Website
http://www.chromistherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$3,000,000 - Transaction Round
Seed - Proceeds Purposes
The company intends to use the funds to advance its platform of antiviral drugs, including cccDNA inhibitors, entry inhibitors and capsid assembly inhibitors, for the treatment of the Hepatitis B virus (HBV). - M&A Terms
- Venture Investor
Torrey Pines Investment - Venture Investor
Undisclosed
